Funded Projects
Explore our currently funded projects. You may search with all three fields, then focus your results by applying any of the dropdown filters. After customizing your search, you may download results and even save your specific search for later.
Project # | Project Title | Research Focus Area | Research Program | Administering IC Sort ascending | Institution(s) | Investigator(s) | Location(s) | Year Awarded |
---|---|---|---|---|---|---|---|---|
4R33NS113329-02
Show Summary |
Discovery of Biomarker Signatures Prognostic for Neuropathic Pain after Acute Spinal Cord Injury | Preclinical and Translational Research in Pain Management | Translating Discoveries into Effective Devices to Treat Pain | NINDS | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT HOUSTON | HERGENROEDER, GEORGENE W | Houston, TX | 2024 |
NOFO Title: Discovery of Biomarkers, Biomarker Signatures, and Endpoints for Pain (R61/R33 Clinical Trial Optional)
NOFO Number: RFA-NS-18-041 |
||||||||
1DP2NS140734-01
Show Summary |
Developing Human Pluripotent Stem Cell Tools for Region-Specific Pain Circuits | Training the Next Generation of Researchers in HEAL | NINDS | TUFTS UNIVERSITY | IYER, NISHA | Boston, MA | 2024 | |
NOFO Title: Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)
NOFO Number: RFA-TR-23-011 |
||||||||
1DP2NS140735-01
Show Summary |
Psychophysical distillation of pure pain by nociceptive-specific heating | Training the Next Generation of Researchers in HEAL | NINDS | EMORY UNIVERSITY | HARPER, DANIEL ELLIOTT | Atlanta, GA | 2024 | |
NOFO Title: Emergency Awards: HEAL Initiative- New Innovator Award (DP2 Clinical Trial Not Allowed)
NOFO Number: RFA-TR-23-011 |
||||||||
1R21NS136065-01
Show Summary |
Exploring the unknown function of LRRC55 in pain | Preclinical and Translational Research in Pain Management | Discovery and Validation of Novel Targets for Safe and Effective Treatment of Pain | NINDS | DUKE UNIVERSITY | YANG, HUANGHE (contact); CHEN, YONG | Durham, NC | 2024 |
NOFO Title: Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed)
NOFO Number: RFA-TR-23-013 |
||||||||
1R21NS136075-01
Show Summary |
Role of Scn1b in Susceptibility to Neuropathic Pain | Preclinical and Translational Research in Pain Management | Discovery and Validation of Novel Targets for Safe and Effective Treatment of Pain | NINDS | UNIVERSITY OF CALIFORNIA BERKELEY | LUMPKIN, ELLEN A (contact); BAUTISTA, DIANA MICHELE | Berkeley, CA | 2024 |
NOFO Title: Emergency Awards: HEAL Initiative-Early-Stage Discovery of New Pain and Opioid Use Disorder Targets Within the Understudied Druggable Proteome (R21 Clinical Trial Not Allowed)
NOFO Number: RFA-TR-23-014 |